z-logo
Premium
Dynamics and kinetics of ophthalmic timolol
Author(s) -
Affrime M B,
Lowenthal D T,
Tobert J A,
Shirk J,
Eidelson B,
Cook T,
Onesti G
Publication year - 1980
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1980.66
Subject(s) - timolol , kinetics , ophthalmology , medicine , glaucoma , physics , classical mechanics
Timolol is a beta adrenergic antagonist in 0.25% or 0.5% eyedrop solution for glaucoma. In a double‐blind crossover study in healthy males we measured systemic beta blockade, intraocular pressure, and timolol kinetics after the first and ninth 12‐hourly dose of a 0.5% ophthalmic solution. Timolol ophthalmic and placebo were each given as 2 drops to each eye with precautions to prevent the normal loss of drug in tears and overflow (high dose) and as 1 drop to each eye with no special precautions (standard therapeutic dose). Exercise tachycardia, measured at 70 and 255 min after administration of drug, was lower at both levels. Postexercise 1‐sec forced expiratory volume (FEV 1 ) was not affected. Intraocular pressure measured at 3 and 8 hr after drug was lower at both dose levels. Timolol was consistently present in urine but was not detectable in most plasma samples. Dynamic effects were not greater after the ninth than after the first dose, and the urinary excretion data provided no evidence of drug cumulation. Clinical Pharmacology and Therapeutics (1980) 27, 471–477; doi: 10.1038/clpt.1980.66

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here